OR WAIT 15 SECS
- Advertise
- Contact Us
- Editorial Contacts
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2020 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
EU Innovation and Competitiveness
Program Co-Chairs Iman Barilero, Johnson & Johnson PRD, and Marie Dray, International Regulatory Affairs Group USA, opened the first plenary session with introductions, sharing their vision of what the 18th Annual DIA EuroMeeting is all about: continuing themes throughout the meeting, including pediatrics, advanced therapies, technology platform, pharmacovigilance, risk management planning, and the involvement of patient groups.
Program Co-Chairs Iman Barilero, Johnson & Johnson PRD, and Marie Dray, International Regulatory Affairs Group USA, opened the first plenary session with introductions, sharing their vision of what the 18th Annual DIA EuroMeeting is all about: continuing themes throughout the meeting, including pediatrics, advanced therapies, technology platform, pharmacovigilance, risk management planning, and the involvement of patient groups.
Marie Dray mentioned that the EuroMeeting will continue Afssaps, involve patient groups, and develop the European Forum-asking regulators questions and discussing what is optimal regulation. Iman Barilero discussed the overall theme of the current environment for innovation and competitiveness in Europe.